[1]
|
American Thoracic Society (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. American Journal of Respiratory and Critical Care Medicine, 165, 277-304.
|
[2]
|
Gross, T.J. and Hunninhake, G.W. (2001) Idiopathic Pulmonary Fibrosis. New England Journal of Medicine, 345, 517-525. http://dx.doi.org/10.1056/NEJMra003200
|
[3]
|
King Jr., T.E. (2003) Idiopathic Interstitial Pneumonia. In: Schwarz, M.I. and King Jr., T.E., Eds., Interstitial Lung Disease, BC Decker Inc., London, 701-786.
|
[4]
|
Katzenstein, A.L. and Fiorelli, R.F. (1994) Nonspecific Interstitial Pneumonia/Fibrosis; Histologic Features and Clinical Significance. American Journal of Surgical Pathology, 18, 136-147.
http://dx.doi.org/10.1097/00000478-199402000-00003
|
[5]
|
Epler, G.R., Colby, T.V., McLoud, T.C., et al. (1985) Bronchiolitis Obliterans Organizing Pneumonia. New England Journal of Medicine, 312, 152-158. http://dx.doi.org/10.1056/NEJM198501173120304
|
[6]
|
Selman, M., Ruiz, V., Cabrea, S., et al. (2000) TIMP-1, -2, -3, and -4 in Idiopathic Pulmonary Fibrosis. A Prevailing Nondegradative Lung Microenvironment? American Journal of Physiology-Lung Cellular and Molecular Physiology, 279, L562-L574.
|
[7]
|
Murphy, G. and Docherty, A.J. (2003) The Matrix Metalloproteinases and Their Inhibitors. American Journal of Medicine, 65, 196-204.
|
[8]
|
Atkinson, J.J. and Senior, R.M. (2003) Matrix Metalloproteinase-9 in Lung Remodeling. American Journal of Respiratory Cell and Molecular Biology, 28, 12-24. http://dx.doi.org/10.1165/rcmb.2002-0166TR
|
[9]
|
Sternlicht, M.D. and Werb, Z. (2001) How Matrix Metalloproteases Regulate Cell Behavior. Annual Review of Cell and Developmental Biology, 17, 463-516. http://dx.doi.org/10.1146/annurev.cellbio.17.1.463
|
[10]
|
Fukuda, Y., Ishizake, M., Kudoh, S., et al. (1998) Localization of Matrix Metalloproteinases-1, -2, and -9, and Tissue Inhibitor of Metalloproteinase-2 in Interstitial Lung Diseases. Laboratory Investigation, 78, 687-698.
|
[11]
|
Lamjabbar, H., Gosset, P., Lechapt-Zalcman, E., Franco-Montoya, M.L., Wallaert, B., Harf, A., et al. (1999) Overexpression of Alveolar Macrophage Gelatinase B (MMP-9) in Patients with Idiopathic Pulmonary Fibrosis: Effects of Steroid and Immunosuppressive Treatment. American Journal of Respiratory Cell and Molecular Biology, 20, 903-913.
http://dx.doi.org/10.1165/ajrcmb.20.5.3260
|
[12]
|
Suga, M., Iyonaga, K., Okamoto, T., Gushima, Y., Miyakawa, H., Akaike, T., et al. (2000) Characteristic Elevation of Matrix Metalloproteinase Activity in Idiopathic Interstitial Pneumonias. American Journal of Respiratory Cell and Critical Care Medicine, 162, 1949-1956. http://dx.doi.org/10.1164/ajrccm.162.5.9906096
|
[13]
|
Pardo, A. and Selman, M. (2006) Matrix Metalloproteases in Aberrant Fibrotic Tissue Remodeling. Proceedings of the American Thoracic Society, 3, 383-388. http://dx.doi.org/10.1513/pats.200601-012TK
|
[14]
|
Choi, K.H., Lee, H., Jeong, M.Y., Rhee, Y.K., Chung, M.J., Kwak, Y.G., et al. (2002) The Role of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Cryptogenic Organizing Pneumonia. Chest, 121, 1478-1485.
http://dx.doi.org/10.1378/chest.121.5.1478
|
[15]
|
Hayashi, T., Stetler-Stevenson, W.G., Fleming, M.V., Fishback, N., Koss, M.N., Liotta, L.A., et al. (1996) Immunohistochemical Study of Metalloproteinases and Their Tissue Inhibitors in the Lungs of Patients with Diffuse Alveolar Damage and Idiopathic Pulmonary Fibrosis. American Journal of Pathology, 149, 1241-1256.
|
[16]
|
Selman, M., King Jr., T.E. and Pardo, A. (2001) Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy. Annals of Internal Medicine, 134, 136-151.
http://dx.doi.org/10.7326/0003-4819-134-2-200101160-00015
|
[17]
|
Okuda, S., Kita, H., George, T.J., Gleich, G.J. and Leiferman, K.M. (1997) Migration of Eosinophils through Basement Membrane Components in Vitro: Role of Metrix Metalloprotease-9. American Journal of Respiratory Cell and Molecular Biology, 17, 519-528. http://dx.doi.org/10.1165/ajrcmb.17.4.2877
|
[18]
|
Madtes, D.K., Eliston, A.L., Kaback, L.A. and Clark, J.G. (2001) Selective Induction of Tissue Inhibitor of Metalloproteinase-1 in Bleomycin-Induced Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology, 24, 599-607. http://dx.doi.org/10.1165/ajrcmb.24.5.4192
|
[19]
|
Pardo, A., Selman, M., Ramaarez, R., Ramos, C., Stricklin, G., Raghu, G., et al. (1992) Production of Collagenase and Tissue Inhibitor of Metalloproteases by Fibroblasts Derived from Normal and Fibrotic Human Lung. Chest, 102, 1085-1089. http://dx.doi.org/10.1378/chest.102.4.1085
|
[20]
|
King Jr., T.E., Schwarz, M.I., Brown, K., Tooze, J.A., Colby, T.V., Waldron Jr., J.A., et al. (2001) Idiopathic Pulmonary Fibrosis. Relationship between Histopathologic Features and Mortality. American Journal of Respiratory and Critical Care Medicine, 164, 1025-1032. http://dx.doi.org/10.1164/ajrccm.164.6.2001056
|
[21]
|
Sienel, W., Hellers, J., Morresihaul, A., Lichtinghagen, R., Mutschler, W., Jochum, M., et al. (2003) Prognostic Impact of Matrix Metalloproteinase-9 in Operable Non-Small Cell Lung Cancer. International Journal of Cancer, 103, 647-651. http://dx.doi.org/10.1002/ijc.10841
|